Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART
- PMID: 28494845
- PMCID: PMC5434880
- DOI: 10.2807/1560-7917.ES.2017.22.18.30529
Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART
Abstract
A new rapid assay for detecting oseltamivir resistance in influenza virus, iART, was used to test 149 clinical specimens. Results were obtained for 132, with iART indicating 41 as 'resistant'. For these, sequence analysis found known and suspected markers of oseltamivir resistance, while no such markers were detected for the remaining 91 samples. Viruses isolated from the 41 specimens showed reduced or highly reduced inhibition by neuraminidase inhibition assay. iART may facilitate broader antiviral resistance testing.
Keywords: air-borne infections; influenza virus; surveillance; viral infections.
This article is copyright of The Authors, 2017.
Conflict of interest statement
Figures
Similar articles
-
Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.Euro Surveill. 2011 Jan 20;16(3):19770. Euro Surveill. 2011. PMID: 21262183
-
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11. N Engl J Med. 2009. PMID: 19907034 No abstract available.
-
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3. J Clin Virol. 2010. PMID: 19962344
-
Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17. J Clin Virol. 2011. PMID: 21684202 Review.
-
[Drug-resistant influenza viruses: an overview].Nihon Rinsho. 2010 Sep;68(9):1671-8. Nihon Rinsho. 2010. PMID: 20845746 Review. Japanese.
Cited by
-
Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients.Emerg Microbes Infect. 2018 Mar 7;7(1):21. doi: 10.1038/s41426-018-0023-3. Emerg Microbes Infect. 2018. PMID: 29511170 Free PMC article. Clinical Trial.
-
Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.Antiviral Res. 2018 Jan;149:118-142. doi: 10.1016/j.antiviral.2017.11.013. Epub 2017 Nov 21. Antiviral Res. 2018. PMID: 29162476 Free PMC article.
-
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.Antiviral Res. 2018 Sep;157:38-46. doi: 10.1016/j.antiviral.2018.07.001. Epub 2018 Jul 3. Antiviral Res. 2018. PMID: 29981793 Free PMC article.
-
Optimization of an Inclusion Body-Based Production of the Influenza Virus Neuraminidase in Escherichia coli.Biomolecules. 2022 Feb 19;12(2):331. doi: 10.3390/biom12020331. Biomolecules. 2022. PMID: 35204831 Free PMC article.
-
Editorial: Novel Vaccine Technologies in Animal Health.Front Vet Sci. 2022 Feb 25;9:866908. doi: 10.3389/fvets.2022.866908. eCollection 2022. Front Vet Sci. 2022. PMID: 35296057 Free PMC article. No abstract available.
References
-
- Takashita E, Kiso M, Fujisaki S, Yokoyama M, Nakamura K, Shirakura M, et al. Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. Antimicrob Agents Chemother. 2015;59(5):2607-17. 10.1128/AAC.04836-14 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources